{"id":7303,"date":"2021-12-16T07:21:43","date_gmt":"2021-12-16T12:21:43","guid":{"rendered":"https:\/\/puyapeptide.net\/product\/carperitide-acetate-anp-1-28-human-cas-89213-87-6-untuk-rawatan-kegagalan-jantung-kongestif\/"},"modified":"2021-12-16T07:21:43","modified_gmt":"2021-12-16T12:21:43","slug":"carperitide-acetate-anp-1-28-human-cas-89213-87-6-untuk-rawatan-kegagalan-jantung-kongestif","status":"publish","type":"product","link":"https:\/\/puyapeptide.net\/ms\/product\/carperitide-acetate-anp-1-28-human-cas-89213-87-6-untuk-rawatan-kegagalan-jantung-kongestif\/","title":{"rendered":"Carperitide Acetate\/ ANP 1-28, HUMAN CAS 89213-87-6 Untuk rawatan kegagalan jantung kongestif"},"content":{"rendered":"

Carperitide Acetate\/ ANP 1-28, HUMAN CAS 89213-87-6 Untuk rawatan kegagalan jantung kongestif<\/strong><\/h2>\n

Nama Produk: Carperitide Acetate\/ ANP 1-28, HUMAN
\nJujukan\uff1a H-Ser-Leu-Arg-Arg-Ser-Ser-Cys-Phe-Gly-Gly-Arg-Met-Asp-Arg- Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys-Asn-Ser-Phe-Arg-Tyr-OH\uff0c(Jambatan disulfida: Cys-Cys)
\nSinonim: ATRIAL NATRIURETIC PEPTIDE HUMAN;SER- LEU-ARG-ARG-SER-SER-CYS-PHE-GLY-GLY-ARG-MET: O-ASP-ARG-ILE-GLY-ALA-GLN-SER-GLY-LEU-GLY-CYS-ASN-SER- PHE-ARG-TYR[SLRRSSCFGGR-MET: O-DRIGAQSGLGCNSFRY]DISULFIDE BRIDGE CYS7-CYS23.;Carperitide Acetate, carperitida;Atrial Natriuretic Peptide (1-28) (manusia) (trifluoroacetate salt);ahANH, Carperitide-de Leu-Arg-Arg-Ser-Ser-Cys-Phe-Gly-Gly-Arg-Met-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys-Asn-Ser-Phe- Arg-Tyr-OH;Atrial natriureticpeptide-28 (manusia) (9CI);Atrial NatriureticFactor (1-28) (manusia) \u03b1hANF, Carperitide
\nCAS: 89213-87-6
\nMF: C127H203N45O39S3
\n MW: 3080.44
\nEINECS: 686-482-9
\nKategori Produk: peptida
\nFail Mol: 89213-87-6.mol<\/p>\n

Carperitide ialah polipeptida asid amino 28 dengan sekunder yang stabil struktur dan merupakan cir hormon kulatori yang bertindak sebagai vasodilator dan diuretik. Dalam amalan klinikal, vasodilasi yang disebabkan oleh carperitide sebagai bahan utama adalah disebabkan oleh pengikatan kepada reseptor ANP (atrial natriuretic polypeptide) dalam otot licin vaskular, yang dicapai dengan meningkatkan aktiviti guanylate cyclase, mencadangkan pengurangan dalam pra dan beban selepas jantung. <\/p>\n

Carperitide ialah \u03b1-human atrial natriuretic peptide (\u03b1-hANP) yang dihasilkan oleh teknologi rekombinan. Ia diperkenalkan di Jepun sebagai rawatan untuk kegagalan jantung kongestif akut (CHF). Pada anjing dengan CHF, karperitida mengurangkan dengan ketara tekanan akhir diastolik ventrikel kiri yang tinggi dan indeks penggunaan oksigen miokardium (tekanan darah sistolik x kadar denyutan jantung). Dalam percubaan klinikal, carperitide berkesan dalam meningkatkan hemodinamik dan gejala dalam 60% pesakit dengan CHF akut. Carperitide dilaporkan boleh diterima dengan baik tanpa kesan buruk yang ketara secara klinikal. Kesan yang baik terhadap hemodinamik telah dilaporkan dalam pesakit kegagalan jantung kronik. Carperitide juga dalam ujian klinikal untuk mengekalkan tekanan darah semasa operasi pembedahan.<\/p>\n

Permohonan<\/strong>
\nRawatan kegagalan jantung kongestif dekompensasi.<\/p>\n","protected":false},"excerpt":{"rendered":"

Nama Produk: Carperitide Acetate\/ ANP 1-28, HUMAN
\nCAS: 89213-87-6
\nMF: C127H203N45O39S3
\nMW: 3080.44
\nEINECS: 686-482-9
\nMol File: 89213-87-6.mol<\/p>\n","protected":false},"featured_media":4556,"comment_status":"open","ping_status":"closed","template":"","meta":{"om_disable_all_campaigns":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"site-sidebar-layout":"default","site-content-layout":"default","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}}},"product_brand":[],"product_cat":[501],"product_tag":[2459,2481],"class_list":{"0":"post-7303","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-peptida-sistem-kardiovaskular","7":"product_tag-carperitide-acetate-anp-1-28-ms","8":"product_tag-human-cas-89213-87-6-for-treatment-of-congestive-heart-failure-ms","9":"desktop-align-left","10":"tablet-align-left","11":"mobile-align-left","13":"first","14":"instock","15":"shipping-taxable","16":"product-type-simple"},"_links":{"self":[{"href":"https:\/\/puyapeptide.net\/ms\/wp-json\/wp\/v2\/product\/7303","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/puyapeptide.net\/ms\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/puyapeptide.net\/ms\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/puyapeptide.net\/ms\/wp-json\/wp\/v2\/comments?post=7303"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/puyapeptide.net\/ms\/wp-json\/wp\/v2\/media\/4556"}],"wp:attachment":[{"href":"https:\/\/puyapeptide.net\/ms\/wp-json\/wp\/v2\/media?parent=7303"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/puyapeptide.net\/ms\/wp-json\/wp\/v2\/product_brand?post=7303"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/puyapeptide.net\/ms\/wp-json\/wp\/v2\/product_cat?post=7303"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/puyapeptide.net\/ms\/wp-json\/wp\/v2\/product_tag?post=7303"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}